New Bellus Enterprises Co. Ltd

NEW BELLUS ENTERPRISES CO., LTD. is a global pioneer in microbial fermentation technology, headquartered in Tainan City, Taiwan. The company specializes in contract microbial fermentation services, offering a comprehensive portfolio of innovative ingredients including probiotics, postbiotics, and medicinal mushroom fermented ingredients. Their flagship products include the NB®23 Probiotics and Postbiotics lines, as well as a patented Hericium erinaceus Mycelium developed through submerged fermentation technology — the latter having received U.S. FDA New Dietary Ingredient (NDI) status.

New Bellus provides end-to-end ODM/OEM solutions designed to enhance the market competitiveness of their partners. Their service offering spans the full product development lifecycle, including superior raw material supply, formulation development and design, product and technology R&D, efficacy verification, stability and safety assessment, packaging solutions, after-sales support, and business and regulatory consulting. Their ingredients address a wide range of health and wellness categories, including digestive health, immune support, metabolic health, women's health, elderly nutrition, sports nutrition, and allergen-free formulations.

Positioned as an international leader in fermentation-based ingredient innovation, New Bellus combines a dedicated R&D center with advanced manufacturing facilities and a strong portfolio of certifications and industry honors. The company serves global markets with a commitment to scientific rigor, quality, and personalized health solutions, making them a trusted partner for businesses seeking cutting-edge fermentation-derived ingredients.